• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型戈谢病治疗患者肝脏活检的组织形态计量分析

Histomorphometric analysis of liver biopsies of treated patients with Gaucher disease type 1.

作者信息

Starosta Rodrigo Tzovenos, Siebert Marina, Vairo Filippo Pinto E, Costa Bruno Lafaiete de Lima, Ponzoni Christiano Tomaso, Schwartz Ida Vanessa Doederlein, Cerski Carlos Thadeu Schmidt

机构信息

Universidade Federal do Rio Grande do Sul, Graduate Program in Genetics and Molecular Biology, Porto Alegre, RS, Brasil.

Washington University, Department of Pediatrics, Saint Louis, MO, USA.

出版信息

Autops Case Rep. 2021 Aug 20;11:e2021306. doi: 10.4322/acr.2021.306. eCollection 2021.

DOI:10.4322/acr.2021.306
PMID:34458174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8387085/
Abstract

Gaucher disease (GD) is an autosomal recessive lysosomal disorder caused by a disturbance in the metabolism of glucocerebroside in the macrophages. Most of its manifestations - hepatosplenomegaly, anemia, thrombocytopenia, and bone pain - are amenable to a macrophage-target therapy such as enzyme replacement. However, there is increasing evidence that abnormalities of the liver persist despite the specific GD treatment. In this work, we adapted histomorphometry techniques to the study of hepatocytes in GD using liver tissue of treated patients, developing the first morphometrical method for canalicular quantification in immunohistochemistry-stained liver biopsies, and exploring histomorphometric characteristics of GD. This is the first histomorphometric technique developed for canalicular analysis on histological liver biopsy samples.

摘要

戈谢病(GD)是一种常染色体隐性溶酶体疾病,由巨噬细胞中葡萄糖脑苷脂代谢紊乱引起。其大多数表现——肝脾肿大、贫血、血小板减少和骨痛——都适合采用诸如酶替代等巨噬细胞靶向治疗。然而,越来越多的证据表明,尽管进行了特异性GD治疗,肝脏异常仍然存在。在这项研究中,我们将组织形态计量学技术应用于GD患者肝细胞的研究,使用接受治疗患者的肝脏组织,开发了免疫组织化学染色肝活检中胆管定量的首个形态计量学方法,并探索了GD的组织形态计量学特征。这是首个针对肝脏组织活检样本进行胆管分析而开发的组织形态计量学技术。

相似文献

1
Histomorphometric analysis of liver biopsies of treated patients with Gaucher disease type 1.1型戈谢病治疗患者肝脏活检的组织形态计量分析
Autops Case Rep. 2021 Aug 20;11:e2021306. doi: 10.4322/acr.2021.306. eCollection 2021.
2
Hemorrhagic aspects of Gaucher disease.戈谢病的出血方面
Rambam Maimonides Med J. 2014 Oct 29;5(4):e0039. doi: 10.5041/RMMJ.10173. eCollection 2014 Oct.
3
Gaucher Disease: Clinical, Biological and Therapeutic Aspects.戈谢病:临床、生物学及治疗方面
Pathobiology. 2016;83(1):13-23. doi: 10.1159/000440865. Epub 2015 Nov 21.
4
Clinical manifestations and management of Gaucher disease.戈谢病的临床表现与治疗
Clin Cases Miner Bone Metab. 2015 May-Aug;12(2):157-64. doi: 10.11138/ccmbm/2015.12.2.157. Epub 2015 Oct 26.
5
Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.维拉苷酶α,一种用于1型戈谢病的重组人葡萄糖脑苷脂酶替代疗法。
Curr Opin Investig Drugs. 2010 Apr;11(4):472-8.
6
Gaucher disease.戈谢病
Joint Bone Spine. 2008 Mar;75(2):116-24. doi: 10.1016/j.jbspin.2007.06.006. Epub 2007 Aug 31.
7
Gaucher disease: review of the literature.戈谢病:文献综述
Arch Pathol Lab Med. 2008 May;132(5):851-3. doi: 10.5858/2008-132-851-GDROTL.
8
Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data.血浆壳三糖苷酶活性与CCL18水平用于评估I型戈谢病严重程度:个体参与者数据的系统评价与荟萃分析方案
Syst Rev. 2017 Apr 20;6(1):87. doi: 10.1186/s13643-017-0483-x.
9
Non-immune Hemolysis in Gaucher Disease and Review of the Literature.戈谢病中的非免疫性溶血及文献综述
Rambam Maimonides Med J. 2021 Jul 20;12(3):e0025. doi: 10.5041/RMMJ.10446.
10
[A retrospective study on enzyme replacement therapy in patients with Gaucher disease].[戈谢病患者酶替代疗法的回顾性研究]
Zhonghua Er Ke Za Zhi. 2006 Sep;44(9):653-6.

引用本文的文献

1
Nuclear morphometry and chromatin texture changes in hepatocellular carcinoma samples may predict outcomes of liver transplanted patients.肝癌样本的核形态计量学和染色质纹理变化可预测肝移植患者的预后。
BMC Gastroenterol. 2022 Apr 15;22(1):189. doi: 10.1186/s12876-022-02262-5.

本文引用的文献

1
Elastic Fibers Density: a New Parameter of Improvement of NAFLD in Bariatric Surgery Patients.弹性纤维密度:肥胖症患者减重手术后非酒精性脂肪肝改善的一个新参数。
Obes Surg. 2020 Oct;30(10):3839-3846. doi: 10.1007/s11695-020-04722-x.
2
Liver involvement in patients with Gaucher disease types I and III.Ⅰ型和Ⅲ型戈谢病患者的肝脏受累情况
Mol Genet Metab Rep. 2020 Jan 7;22:100564. doi: 10.1016/j.ymgmr.2019.100564. eCollection 2020 Mar.
3
Morphoquantitative effects of oral β-carotene supplementation on liver of C57BL/6 mice exposed to ethanol consumption.
口服β-胡萝卜素补充剂对饮用乙醇的C57BL/6小鼠肝脏的形态定量影响。
Int J Clin Exp Pathol. 2019 May 1;12(5):1713-1722. eCollection 2019.
4
Controlled attenuation parameter and liver stiffness measurements using transient elastography by FibroScan in Gaucher disease.应用 FibroScan 瞬态弹性成像技术检测 Gaucher 病患者的受控衰减参数和肝硬度值。
Mol Genet Metab. 2020 Feb;129(2):125-131. doi: 10.1016/j.ymgme.2019.10.013. Epub 2019 Nov 1.
5
Liver damage in a patient with Gaucher's disease type 1 and alpha-1 antitrypsin deficiency: a potential epigenetic effect?戈谢病 1 型合并α-1 抗胰蛋白酶缺乏症患者的肝损伤:潜在的表观遗传效应?
J Gastrointestin Liver Dis. 2019 Mar;28(1):121-123. doi: 10.15403/jgld.2014.1121.281.gau.
6
Histo-genomics: digital pathology at the forefront of precision medicine.组织基因组学:处于精准医学前沿的数字病理学。
Diagnosis (Berl). 2019 Aug 27;6(3):203-212. doi: 10.1515/dx-2018-0064.
7
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease.1 型戈谢病患者应用振动控制瞬时弹性成像技术评估肝脏纤维化的流行率和预测因子。
Mol Genet Metab. 2018 Sep;125(1-2):64-72. doi: 10.1016/j.ymgme.2018.08.004. Epub 2018 Aug 11.
8
Aluminum Exposure from Parenteral Nutrition: Early Bile Canaliculus Changes of the Hepatocyte.从肠外营养中摄入的铝:肝细胞的早期胆小管改变。
Nutrients. 2018 Jun 4;10(6):723. doi: 10.3390/nu10060723.
9
Correlating liver stiffness with disease severity scoring system (DS3) values in Gaucher disease type 1 (GD1) patients.将肝硬度与戈谢病 1 型(GD1)患者疾病严重程度评分系统(DS3)值相关联。
Mol Genet Metab. 2018 Mar;123(3):357-363. doi: 10.1016/j.ymgme.2017.10.013. Epub 2018 Jan 5.
10
Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?癌症多药耐药中的鞘脂异常:鸡先有还是蛋先有?
Cell Signal. 2017 Oct;38:134-145. doi: 10.1016/j.cellsig.2017.06.017. Epub 2017 Jul 4.